Baudax Bio, Inc. (BXRXQ)
0.0000
0.00 (0.00%)
USD |
OTCM |
Aug 28, 16:00
Baudax Bio Total Liabilities (Quarterly)
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 30.82M |
| June 30, 2023 | 32.00M |
| March 31, 2023 | 14.38M |
| December 31, 2022 | 34.27M |
| September 30, 2022 | 37.05M |
| June 30, 2022 | 36.60M |
| March 31, 2022 | 39.07M |
| December 31, 2021 | 40.05M |
| September 30, 2021 | 82.23M |
| June 30, 2021 | 78.38M |
| Date | Value |
|---|---|
| March 31, 2021 | 75.98M |
| December 31, 2020 | 83.53M |
| September 30, 2020 | 106.70M |
| June 30, 2020 | 134.89M |
| March 31, 2020 | 110.05M |
| December 31, 2019 | 70.93M |
| September 30, 2019 | 71.41M |
| June 30, 2019 | 67.33M |
| March 31, 2019 | 88.36M |
| December 31, 2018 | 103.37M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 896.90M |
| Corcept Therapeutics, Inc. | 182.93M |
| Veru, Inc. | 8.651M |
| Johnson & Johnson | 116.09B |
| Eli Lilly & Co. | 108.40B |